ACHILLION PHARMACEUTICALS IN's ticker is ACHN and the CUSIP is 00448Q201. A total of 152 filers reported holding ACHILLION PHARMACEUTICALS IN in Q2 2016. The put-call ratio across all filers is 0.32 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $40,000 | +8.1% | 24,815 | +88.3% | 0.01% | +16.7% |
| Q2 2018 | $37,000 | -65.7% | 13,178 | -64.5% | 0.01% | -68.4% |
| Q4 2017 | $108,000 | -21.7% | 37,171 | +13.5% | 0.02% | -40.6% |
| Q1 2017 | $138,000 | -68.1% | 32,757 | -41.0% | 0.03% | -72.6% |
| Q2 2016 | $433,000 | +263.9% | 55,521 | +260.4% | 0.12% | +265.6% |
| Q1 2016 | $119,000 | – | 15,407 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 13,633,220 | $57,396,000 | 7.04% |
| HealthInvest Partners AB | 497,807 | $2,096,000 | 3.21% |
| BVF INC/IL | 3,285,400 | $13,832,000 | 2.35% |
| EMORY UNIVERSITY | 486,438 | $2,048,000 | 1.93% |
| Marcus Capital, LLC | 69,400 | $1,751,000 | 1.63% |
| DAFNA Capital Management LLC | 196,500 | $827,000 | 0.70% |
| Orbimed Advisors | 13,107,200 | $55,181,000 | 0.62% |
| Rock Springs Capital Management LP | 1,500,000 | $6,315,000 | 0.36% |
| Spark Investment Management LLC | 710,100 | $2,989,000 | 0.19% |
| TURNER INVESTMENTS LLC | 65,420 | $275,000 | 0.18% |